US Military-Industrial-Academic technology bio-partnership framework is set

On January 11, 2016 it was announced that "the U.S. Army Contracting Command, Picatinny Arsenal, New Jersey, on behalf of the Joint Project Manager for Medical Countermeasure Systems (JPM-MCS) through the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), announced its intent to enter into a Section 815 Other Transaction (OT) Agreement with the National Chemical and Biological Defense Consortium (NCBDC) for a period of twenty (20) years. " [1] NCBDC "encompasses the expertise, knowledge, technologies, and innovation to meet the program objectives and goals of the coordinated research and development program designed to support the Department of Defense's medical, pharmaceutical, and diagnostic requirements as related to enhancing the mission effectiveness of military personnel." It includes pharma industry, academic institutions, and not-for-profit partners, "forad vanced development efforts to support the Department of Defense’s (DoD) medical, pharmaceutical and diagnostic requirements as related to enhancing the mission effectiveness of military personnel". [1, 4] The NCBDC is an open consortium with a low barrier for membership. Any interested company, academic institution, or contractor can become a member and join the consortium to widen knowledge and technical expertise to continue to advance in technologies and meet Government needs. On April 8, 2016,..> READ MORE

The Real ID Act of 2005 – the prelude to digital ID and vaccine cards

On the back of 9/11, on January 26, 2005 the US government introduce the federal Real ID Act of 2005 (HR 418), which is passed into law later that year "essentially standardized ID requirements for all states" or centralising control! The legislation is implemented by the Department of Homeland Security. [1, 2] By January 2019 it is recognised this centralised/standardised ID system is an international reaching program, with control repercussions for everyone. Making it impossible to work, make a living, travel without their ID! [@1:05:45] Argentina added a "vaccination card" [@52min] to their drivers licence in December 2018, which happened to be the country where Pfizer concentrated their COVID-19 vaccine phase III clinical trial - coincidence? [3]
Vaccination Mandates
Posted inCOVID-19 Vaccines

Vaccine Mandates

A page to capture COVID-19 vaccine "approval" and rollout dates and when vaccine mandates were implemented for as many parts of the world as I can managed to capture...so history does not get forgotten. As vaccine mandates began to faze…
15 December 2023Posted inCOVID-19 Vaccines

FDA pushes EUA regulatory pathway for CV19 jabs and not EAU – bypassing “informed consent” etc.

At the 161st FDA VRPBAC meeting on October 22, 2020 Dr Doran Fink expained why the regulatory pathway for the COVID-19 vaccines should follow the "regulatory standard" of EUA and not EAU. The differences between expanded access use and Emergency Use Authorization are that expanded access use is done -- or is carried out under FDA's investigational new drug regulations. So among many other things, those regulations require use of an institutional review board and also obtaining informed consent from recipients of the investigational vaccine according to regulations for clinical investigations -- research use of investigational vaccines. And so operationally speaking, an expanded access protocol would add some complexity, and that is why Emergency Use Authorization is being considered primarily as the mechanism for addressing the public health emergency that has been declared. Dr Fink, [from pg 203] Dr Fink went on to work for Moderna! "The FDA officials clearly explained here that the reason they went with EUA is specifically NOT to follow any investigational drug rules or cGxP, and NOT to provide informed consent" completely legal while under a declared Public Health Emergency (PHE)! [1] So how did the mRNA products that were not subject to investigational drug..> READ MORE

UN OCHA is established

On December 19, 1991 at the United Nations General Assembly the members adopt UN resolution 46/182, which called for stronger international leadership in response to complex emergencies and natural disasters as a result the UN Office for the Coordination of Humanitarian Affairs (OCHA) was established. [1, 2] OCHA's Relief Web news site reports on relief activities such as profits made by mRNA COVID-19 vaccine manufactures while poor countries remain unvaccinated!

UN: mRNA vaccine companies profiting $93.5 million per day!

On November 16-18, 2021 Big Pharma CEO's meet a the annual STAT summit —the equivalent of a ‘Big Pharma Davos’. At the time their latest reports from the companies who produce the new technology mRNA vaccines - Pfizer, BioNTech and Moderna - revealedd that they are making combined profits of $65,000 every minute, or equivalent to or $93.5 million a day. "The monopolies these companies hold have produced five new billionaires during the pandemic, with a combined net wealth of $35.1 billion" reports the United Nations "relief web". As of October 21, 2021 "Moderna has only delivered 0.2 percent of their total vaccine supply to low-income countries and Pfizer/BioNTech has delivered less than 1 percent" as reported by Oxfam's People’s Vaccine Alliance [1, 2].  As WHO's D.G. Tedros pushes for more vaccines into poorer countries. [Those coutries with less COVID-19 vaccines had lower death rates from COVID-19]
Moderna FOIA documents
Posted inCOVID-19 Vaccines

Moderna FOIA Documents

Following the Food and Drug Administration's (FDA) licensing of Moderna's COVID-19 vaccine, they were requested by law firm Siri & Glimstad on behalf of their client Public Health and Medical Professionals for Transparency (PHMPT), to release under the Freedom of…
9 September 2023Posted inCOVID-19 Vaccines